Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biotinylated idraparinux versus warfarin for symptomatic pulmonary embolism
2006-001786-42Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pulmonary embolism (PE) and deep vein thrombosis (DVT) comparing Biotinylated idraparinux with Warfarin (2 arms). Primary endpoint: Symptomatic recurrent venous thromboembolism within 3 months. Started May 2006; status: completed.
02
Drugs
SSR-126517Ewarfarin
03
Conditions
pulmonary embolism (PE)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on 2006-001786-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001786-42.